Family-owned pharma: Performed financial diagnostic and growth strategy evaluation

ConsultingStrategyHealthcare
Written By Andrew Leon Hanna

Performed financial diagnostic and growth strategy evaluation for a $50M family-owned pharmaceutical manufacturing group in Kenya, working directly with the CEO and Board. Evaluated financial options for each business unit and the combined Group operations. 

Andrew Leon Hanna
Previous

DFI: Developed Africa manufacturing sector investment strategy
Next

Fortune 500 company: Developed sustainable operations plan and impact investing strategy